Summary: Appropriate Use Criteria for Estrogen Receptor–Targeted PET Imaging with 16α-<sup>18</sup>F-Fluoro-17β-Fluoroestradiol-Reference-Cited by-同舟云学术

Summary: Appropriate Use Criteria for Estrogen Receptor–Targeted PET Imaging with 16α-¹⁸F-Fluoro-17β-Fluoroestradiol

Published:2023-03 Issue:3 Volume:64 Page:351-354
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Ulaner Gary A.,Mankoff David A.,Clark Amy S.,Fowler Amy M.,Linden Hannah M.,Peterson Lanell M.,Dehdashti Farrokh,Kurland Brenda F.,Mortimer Joanne,Mouabbi Jason,Moon Dae Hyuk,de Vries Elisabeth G.E.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference57 articles.

1. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

2. Whole-body characterization of estrogen receptor status in metastatic breast cancer with 16α-18F-fluoro-17β-estradiol positron emission tomography: meta-analysis and recommendations for integration into clinical applications;Kurland;Oncologist.,2020

3. Between-Patient and Within-Patient (Site-to-Site) Variability in Estrogen Receptor Binding, Measured In Vivo by 18F-Fluoroestradiol PET

4. The assessment of estrogen receptor status and its intratumoral heterogeneity in patients with breast cancer by using 18F-dluoroestradiol PET/CT;Yang;Clin Nucl Med.,2017

5. 18F-fluoroestradiol tumor uptake is heterogeneous and influenced by site of metastasis in breast cancer patients;Nienhuis;J Nucl Med.,2018

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estrogen Receptor–targeted PET Imaging for Breast Cancer;Radiology;2024-08-01

2. Utility of ¹⁸ F-fluoroestradiol over ¹⁸ F-fluorodeoxyglucose positron emission tomography/computed tomography in the initial diagnosis of over 90 metastatic lesions in a patient with metastatic estrogen receptor–positive breast cancer;Baylor University Medical Center Proceedings;2024-07-29

3. ER-Targeted PET for Initial Staging and Suspected Recurrence in ER-Positive Breast Cancer;JAMA Network Open;2024-07-26

4. 16α-¹⁸F-Fluoro-17β-Estradiol PET/CT—A Tool for Staging Estrogen Receptor–Expressing Breast Cancer?;JAMA Network Open;2024-07-26

5. Novel PET tracers in breast cancer for treatment optimization: clinical utility and future perspectives;Current Opinion in Oncology;2024-06-13